Lapatinib 250 mg · Strip

Lapahope 250 Mg Tablet 30’s

Rx (Prescription Medicine)

USD $ 30.00

USD $ 1.00 per tablet

Upload prescription Ask about this medicine
  • Dispatched from licensed pharmacy partners
  • Tracked worldwide shipping
  • Secure payment

Lapahope 250mg Tablet is a tyrosine kinase inhibitor used to treat HER2-positive breast cancer. It works by blocking proteins that promote cancer cell growth.

Key facts

Active ingredient
Lapatinib
Strength
250 mg
Form
Tablet
Drug class
Generic
Brand
Lapahope
Manufacturer
Glenmark Pharmaceuticals
Pack sizes
30 Tablets

Description

Lapahope 250mg Tablet is a medication containing the active ingredient Lapatinib. Lapatinib is a tyrosine kinase inhibitor that works by blocking the activity of certain proteins that help cancer cells grow and divide. It is primarily used in the treatment of certain types of breast cancer, specifically HER2-positive breast cancer, in combination with other medications. Lapahope 250mg Tablet is typically prescribed by a healthcare professional and the dosage and duration of treatment will depend on the individual patient’s condition and response to therapy. Common side effects may include diarrhea, rash, nausea, and fatigue. It is important to discuss any potential side effects or concerns with your doctor. Lapahope 250mg Tablets should be stored at room temperature, away from moisture and heat, and out of reach of children.

Additional information

Medicine Form

Tablet

Rx Status

Prescription Required

Medicine Type

Allopathy

Molecule

Lapatinib

Pack Quantity

30's

Strength

250mg

Brand Name

Molecule

Strength

250 mg

Medicine Form

Tablet

Pack Quantity

30 Tablets

Packaging Type

Strip

Medicine Type

Generic

Country Of Origin

India

Rx Status

Rx (Prescription Medicine)

Same molecule & strength

Other brands of Lapatinib 250 mg — the same active ingredient at the same strength, from a different manufacturer.

On this page
  1. Key facts
  2. Description
  3. Additional information
  4. Same molecule

Content integrity

Medically reviewed by

Renu Meena, B.Pharm

Medical Content Writer

Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.

Last reviewed 11/08/2026

Shipping to your country

Options
Fast Delivery – Arrives in 7–12 Days, Express shipping (Arriving in 3-7 days )
Free over
USD $ 200.00